<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="interaction" /><meta name="keywords" content="" /><title>Acenocoumarol: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="bnf_int221-acenocoumarol.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="bnf_int221-acenocoumarol.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=bnf_int221-acenocoumarol.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 07 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP8848-interactions.htm">Appendix 1 Interactions</a> &gt; <a href="PHP8852-list-of-drug-interactions.htm">List of drug interactions</a> &gt; <a href="bnf_int219-anticoagulants.htm">Anticoagulants</a> &gt; <a href="bnf_int220-coumarins.htm">Coumarins</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="bnf_int220-coumarins.htm" title="Previous: Coumarins">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="bnf_int222-warfarin.htm" title="Next: Warfarin">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Acenocoumarol</h1><?highlighter on?><div id="pC" class="jN"><p><strong>Acenocoumarol</strong> has no specific interaction information.</p><p><strong>Acenocoumarol</strong> belongs to <strong>Coumarins</strong> and will have the following interaction information:</p><div class="cG"><p><strong>Note:</strong> Change in patient's clinical condition, particularly associated with liver disease, intercurrent illness, or drug administration, necessitates more frequent testing. Major changes in diet (especially involving salads and vegetables) and in alcohol consumption may also affect anticoagulant control</p></div><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int683-acitretin.htm">Acitretin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly reduced by</span> <span>acitretin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int20-alcohol.htm">Alcohol</a></td><td class="cAI"><p><span>anticoagulant control with </span> <span>coumarins</span> <span>may be affected by major changes in consumption of</span> <span>alcohol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int22-allopurinol.htm">Allopurinol</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>allopurinol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int118-amiodarone.htm">Amiodarone</a></td><td class="cAI"><p><span>metabolism of </span> <span>coumarins</span> <span>inhibited by</span> <span>amiodarone</span> <span>(enhanced anticoagulant effect)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Amiodarone has a long half-life; there is a potential for drug interactions to occur for several weeks (or even months) after treatment with it has been stopped</p></div></td></tr><tr><td><a href="bnf_int36-anabolic-steroids.htm">Anabolic Steroids</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>anabolic steroids</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int232-antidepressants-ssri.htm">Antidepressants, SSRI</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>SSRIs</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int241-antidepressants-tricyclic.htm">Antidepressants, Tricyclic</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>may be enhanced or reduced by</span> <span>tricyclics</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int361-aspirin.htm">Aspirin</a></td><td class="cAI"><p><span>increased risk of bleeding when </span> <span>coumarins</span> <span>given with</span> <span>aspirin</span> <span>(due to antiplatelet effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int519-azathioprine.htm">Azathioprine</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly reduced by</span> <span>azathioprine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int167-azithromycin.htm">Azithromycin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>azithromycin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int172-aztreonam.htm">Aztreonam</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>aztreonam</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int578-bicalutamide.htm">Bicalutamide</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>bicalutamide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int943-bosentan.htm">Bosentan</a></td><td><p><span>monitoring anticoagulant effect of </span> <span>coumarins</span> <span>recommended by manufacturer of</span> <span>bosentan</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int277-carbamazepine.htm">Carbamazepine</a></td><td class="cAI"><p><span>metabolism of </span> <span>coumarins</span> <span>accelerated by</span> <span>carbamazepine</span> <span>(reduced anticoagulant effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int141-cephalosporins.htm">Cephalosporins</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>cephalosporins</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int422-chloral.htm">Chloral</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>may transiently be enhanced by</span> <span>chloral</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int158-chloramphenicol.htm">Chloramphenicol</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>chloramphenicol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int744-cimetidine.htm">Cimetidine</a></td><td class="cAI"><p><span>metabolism of </span> <span>coumarins</span> <span>inhibited by</span> <span>cimetidine</span> <span>(enhanced anticoagulant effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int195-ciprofloxacin.htm">Ciprofloxacin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>ciprofloxacin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int168-clarithromycin.htm">Clarithromycin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>clarithromycin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int865-clopidogrel.htm">Clopidogrel</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced due to antiplatelet action of</span> <span>clopidogrel</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int592-colestyramine.htm">Colestyramine</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>may be enhanced or reduced by</span> <span>colestyramine</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Other drugs should be taken at least 1 hour before or 4–6 hours after colestyramine to reduce possible interference with absorption</p></div></td></tr><tr><td><a href="bnf_int484-corticosteroids.htm">Corticosteroids</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>may be enhanced or reduced by</span> <span>corticosteroids</span> <span>(high-dose <span>corticosteroids</span> enhance anticoagulant effect)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not generally apply to corticosteroids used for topical action (including inhalation) unless specified</p></div></td></tr><tr><td><a href="bnf_int995-cranberry-juice.htm">Cranberry Juice</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>cranberry juice</span> <span>—avoid concomitant use</span>  </p></td><td></td></tr><tr><td><a href="bnf_int579-danazol.htm">Danazol</a></td><td class="cAI"><p><span>metabolism of </span> <span>coumarins</span> <span>inhibited by</span> <span>danazol</span> <span>(enhanced anticoagulant effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int362-dipyridamole.htm">Dipyridamole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced due to antiplatelet action of</span> <span>dipyridamole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int523-disulfiram.htm">Disulfiram</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>disulfiram</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1176-dronedarone.htm">Dronedarone</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>dronedarone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int830-enteral-foods.htm">Enteral Foods</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>antagonised by vitamin K (present in some</span> <span>enteral feeds</span> <span>)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1048-erlotinib.htm">Erlotinib</a></td><td class="cAI"><p><span>increased risk of bleeding when </span> <span>coumarins</span> <span>given with</span> <span>erlotinib</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int169-erythromycin.htm">Erythromycin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>erythromycin</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to small amounts of erythromycin used topically</p></div></td></tr><tr><td><a href="bnf_int914-esomeprazole.htm">Esomeprazole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>esomeprazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1031-etoposide.htm">Etoposide</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>etoposide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int970-ezetimibe.htm">Ezetimibe</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>ezetimibe</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int594-fibrates.htm">Fibrates</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>fibrates</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int301-fluconazole.htm">Fluconazole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>fluconazole</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> In general, fluconazole interactions relate to multiple-dose treatment</p></div></td></tr><tr><td><a href="bnf_int509-fluorouracil.htm">Fluorouracil</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>fluorouracil</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int580-flutamide.htm">Flutamide</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>flutamide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int603-fluvastatin.htm">Fluvastatin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>fluvastatin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1019-fosamprenavir.htm">Fosamprenavir</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>may be enhanced or reduced by</span> <span>fosamprenavir</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Fosamprenavir is a prodrug of amprenavir</p></div></td></tr><tr><td><a href="bnf_int291-griseofulvin.htm">Griseofulvin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>reduced by</span> <span>griseofulvin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int825-ifosfamide.htm">Ifosfamide</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>ifosfamide</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1015-iloprost.htm">Iloprost</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>iloprost</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int302-itraconazole.htm">Itraconazole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>itraconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int298-ketoconazole.htm">Ketoconazole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>ketoconazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1098-lactulose.htm">Lactulose</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>lactulose</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int840-levofloxacin.htm">Levofloxacin</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>levofloxacin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int510-mercaptopurine.htm">Mercaptopurine</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly reduced by</span> <span>mercaptopurine</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int718-methylphenidate.htm">Methylphenidate</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>methylphenidate</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int170-metronidazole.htm">Metronidazole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>metronidazole</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to topical metronidazole preparations </p></div></td></tr><tr><td><a href="bnf_int299-miconazole.htm">Miconazole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>miconazole</span> <span>(<span>miconazole</span> oral gel and possibly vaginal and topical formulations absorbed)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1057-mitotane.htm">Mitotane</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly reduced by</span> <span>mitotane</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int60-nsaids.htm">NSAIDs</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>NSAIDs</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> See also Aspirin. Interactions do not generally apply to topical NSAIDs
</p></div></td></tr><tr><td><a href="bnf_int196-nalidixic-acid.htm">Nalidixic Acid</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>nalidixic acid</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int133-neomycin.htm">Neomycin</a></td><td class="cAI"><p><span>experience in anticoagulant clinics suggests that INR possibly altered when </span> <span>coumarins</span> <span>are given with</span> <span>neomycin</span> <span>(given for local action on gut)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int197-norfloxacin.htm">Norfloxacin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>norfloxacin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int636-oestrogens.htm">Oestrogens</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>may be enhanced or reduced by</span> <span>oestrogens</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a title="COCs interactions (target-block)" href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a></p></div></td></tr><tr><td><a href="bnf_int198-ofloxacin.htm">Ofloxacin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>ofloxacin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int752-omeprazole.htm">Omeprazole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>omeprazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int856-orlistat.htm">Orlistat</a></td><td><p><span>monitoring anticoagulant effect of </span> <span>coumarins</span> <span>recommended by manufacturer of</span> <span>orlistat</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int754-pantoprazole.htm">Pantoprazole</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>pantoprazole</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int59-paracetamol.htm">Paracetamol</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by prolonged regular use of</span> <span>paracetamol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int174-penicillins.htm">Penicillins</a></td><td><p><span>an interaction between </span> <span>coumarins</span> <span>and broad-spectrum</span> <span>penicillins</span> <span>has not been demonstrated in studies, but common experience in anticoagulant clinics is that INR can be altered</span>  </p></td><td></td></tr><tr><td><a href="bnf_int437-phenobarbital.htm">Phenobarbital</a></td><td class="cAI"><p><span>metabolism of </span> <span>coumarins</span> <span>accelerated by</span> <span>phenobarbital</span> <span>(reduced anticoagulant effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int284-phenytoin.htm">Phenytoin</a></td><td class="cAI"><p><span>metabolism of </span> <span>coumarins</span> <span>accelerated by</span> <span>phenytoin</span> <span>(possibility of reduced anticoagulant effect, but enhancement also reported)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int1146-prasugrel.htm">Prasugrel</a></td><td><p><span>possible increased risk of bleeding when </span> <span>coumarins</span> <span>given with</span> <span>prasugrel</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int664-progestogens.htm">Progestogens</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>may be enhanced or reduced by</span> <span>progestogens</span> <span></span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions of combined oral contraceptives may also apply to combined contraceptive patches and vaginal rings, see <a href="PHP4869-combined-hormonal-contraceptives.htm#PHP4875">section 7.3.1</a>. For further information on interactions of oral progestogen-only contraceptives, see also <a href="PHP4944-oral-progestogen-only-contraceptives.htm#PHP4945">section 7.3.2.1</a>; parenteral progestogen-only contraceptives, see also <a href="PHP4960-parenteral-progestogen-only-contraceptives.htm#PHP4965">section 7.3.2.2</a>; the intra-uterine progestogen-only device, see also <a href="PHP4973-intra-uterine-progestogen-only-device.htm#PHP4974">section 7.3.2.3</a>; hormonal emergency contraception, see also <a href="PHP5019-hormonal-methods.htm#PHP5024">section 7.3.5</a></p></div></td></tr><tr><td><a href="bnf_int125-propafenone.htm">Propafenone</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>propafenone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int864-raloxifene.htm">Raloxifene</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>antagonised by</span> <span>raloxifene</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int199-rifamycins.htm">Rifamycins</a></td><td class="cAI"><p><span>metabolism of </span> <span>coumarins</span> <span>accelerated by</span> <span>rifamycins</span> <span>(reduced anticoagulant effect)</span>  </p></td><td><div class="cG"><p><strong>Note:</strong> Interactions do not apply to rifaximin</p></div></td></tr><tr><td><a href="bnf_int400-ritonavir.htm">Ritonavir</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>ritonavir</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int974-rosuvastatin.htm">Rosuvastatin</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>rosuvastatin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int605-simvastatin.htm">Simvastatin</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>simvastatin</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1074-sorafenib.htm">Sorafenib</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>sorafenib</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int905-st-johns-wort.htm">St John's Wort</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>reduced by</span> <span>St John's wort</span> <span>(avoid concomitant use)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int755-sucralfate.htm">Sucralfate</a></td><td class="cAI"><p><span>absorption of </span> <span>coumarins</span> <span>possibly reduced by</span> <span>sucralfate</span> <span>(reduced anticoagulant effect)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int689-sulfinpyrazone.htm">Sulfinpyrazone</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>sulfinpyrazone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int203-sulfonamides.htm">Sulfonamides</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>sulfonamides</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int268-sulfonylureas.htm">Sulfonylureas</a></td><td class="cAI"><p><span></span> <span>coumarins</span> <span>possibly enhance hypoglycaemic effect of</span> <span>sulfonylureas</span> <span>, also possible changes to anticoagulant effect</span>  </p></td><td></td></tr><tr><td><a href="bnf_int581-tamoxifen.htm">Tamoxifen</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>tamoxifen</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1035-testolactone.htm">Testolactone</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>testolactone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int814-testosterone.htm">Testosterone</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>testosterone</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int209-tetracyclines.htm">Tetracyclines</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>tetracyclines</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int935-thyroid-hormones.htm">Thyroid Hormones</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>thyroid hormones</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1069-tigecycline.htm">Tigecycline</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>tigecycline</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int582-toremifene.htm">Toremifene</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>toremifene</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int106-tramadol.htm">Tramadol</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>tramadol</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int217-trimethoprim.htm">Trimethoprim</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>trimethoprim</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int286-valproate.htm">Valproate</a></td><td><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>valproate</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int1134-vitamin-e.htm">Vitamin E</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>possibly enhanced by</span> <span>vitamin E</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int769-vitamin-k-phytomenadione.htm">Vitamin K (Phytomenadione)</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>antagonised by</span> <span>vitamin K</span> <span></span>  </p></td><td></td></tr><tr><td><a href="bnf_int948-voriconazole.htm">Voriconazole</a></td><td class="cAI"><p><span>anticoagulant effect of </span> <span>coumarins</span> <span>enhanced by</span> <span>voriconazole</span> <span></span>  </p></td><td></td></tr></tbody></table><p><strong>Acenocoumarol</strong> belongs to <strong>Anticoagulants</strong> and will have the following interaction information:</p><table summary="Drug interactions" width="100%" border="0" cellspacing="2"><colgroup><col width="30%" class="cAG" /><col width="40%" class="cAF" /><col width="30%" class="cAH" /></colgroup><tbody><tr><td><a href="bnf_int64-diclofenac.htm">Diclofenac</a></td><td class="cAI"><p><span>increased risk of haemorrhage when </span> <span>anticoagulants</span> <span>given with intravenous</span> <span>diclofenac</span> <span>(avoid concomitant use, including low-dose heparins)</span>  </p></td><td></td></tr><tr><td><a href="bnf_int72-ketorolac.htm">Ketorolac</a></td><td class="cAI"><p><span>increased risk of haemorrhage when </span> <span>anticoagulants</span> <span>given with</span> <span>ketorolac</span> <span>(avoid concomitant use, including low-dose heparins)</span>  </p></td><td></td></tr></tbody></table></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="bnf_int220-coumarins.htm">Previous: Coumarins</a> | <a class="top" href="bnf_int221-acenocoumarol.htm#">Top</a> | <a accesskey="]" href="bnf_int222-warfarin.htm">Next: Warfarin</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>